Blood · 1997 · 107 citations · 25 references
Life SciencesImmunologyMolecular BiologyHost-pathogen InteractionsInflammationInnate ImmunityFungal ImmunologyFungal InfectionsFungal PathogenesisGranulomatous InflammationHost Defense Against InfectionImmune Responses To InfectionChronic Fungal GranulomasChronic Granulomatous DiseaseGranuloma Formation In Fungal InfectionGranulomatous ReactionsHost Defense Against Bacterial InfectionHost Defense Against PathogensRetroviral Gene Transfer
Abstract The X-linked form of chronic granulomatous disease (X-CGD), an inherited deficiency of the respiratory burst oxidase, results from mutations in the X-linked gene for gp91phox, the larger subunit of the oxidase cytochrome b. The goal of this study was to evaluate the impact of retroviral-mediated gene transfer of gp91phox on host defense against Aspergillus fumigatus in a murine model of X-CGD. Retrovirus vectors constructed using the murine stem cell virus (MSCV) backbone were used for gene transfer of the gp91phox cDNA into murine X-CGD bone marrow cells. Transduced cells were transplanted into lethally irradiated syngeneic X-CGD mice. After hematologic recovery, superoxide production, as monitored by the nitroblue tetrazolium (NBT) test, was detected in up to ≈80% of peripheral blood neutrophils for at least 28 to 35 weeks after transplantation. Neutrophil expression of recombinant gp91phox and superoxide production were significantly less than wild-type neutrophils. However, 9 of 9 mice with ≈50% to 80% NBT+ neutrophils after gene transfer did not develop lung disease after respiratory challenge with 150 to 500 A fumigatus spores, doses that produced disease in 16 of 16 control X-CGD mice. In X-CGD mice transplanted with mixtures of wild-type and X-CGD bone marrow, ≥5% wild-type neutrophils were required for protection against A fumigatus challenge. These data suggest that expression of even low levels of recombinant gp91phox can substantially improve phagocyte function in X-CGD, although correction of very small percentage of phagocytes may not be sufficient for protection against A fumigatus.
25
Versatile retroviral vectors for potential use in gene therapy.
Robert G. Hawley, F H Lieu, A Z Fong et al. · PubMed · 1994 · 678 citations